A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside (Q47217953)
Jump to navigation
Jump to search
scientific article published in July 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside |
scientific article published in July 2004 |
Statements
1 reference
A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside (English)
1 reference
Paul B Chapman
1 reference
Linda Williams
1 reference
Nadia Salibi
1 reference
Wen-Jen Hwu
1 reference
Susan E Krown
1 reference
Philip O Livingston
1 reference
1 July 2004
1 reference
1 reference
22
1 reference
21-22
1 reference
2904-2909
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference